Applied Molecular Transport shares are trading lower after the company announced top-line Phase 2 results from its MARKET combination trial of oral AMT-101 in patients with moderate-to-severe ulcerative colitis.

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!

  • The most trusted brand in stock market news
  • Fatest intelligence & alerts
  • Active trader chat rooms
  • Option trade alerts
  • Only comprehensive mobile notifications solution
  • Welcoming & white glove support
Posted In: WIIM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...